The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo - Wikidata - wikimedia - TriplyDB

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

http://www.wikidata.org/entity/Q34459390

about

Genome-editing Technologies for Gene and Cell Therapy CRISPR/Cas9 and cancer targets: future possibilities and present challenges Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Application of CRISPR/Cas9 Technology to HBV Progress and Prospects of Anti-HBV Gene Therapy Development Epigenome engineering in cancer: fairytale or a realistic path to the clinic?Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes Genome editing: the road of CRISPR/Cas9 from bench to clinic Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis Future Therapy for Hepatitis B Virus: Role of Immunomodulators Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA Therapeutic genome editing: prospects and challenges Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.CRISPR/Cas9 in allergic and immunologic diseases.CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus Hepatitis B virus: new therapeutic perspectives.Genome editing and the next generation of antiviral therapy.Applications of CRISPR technologies in research and beyond.The CRISPR/Cas9 genome editing methodology as a weapon against human viruses CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication.CRISPR/Cas9-The ultimate weapon to battle infectious diseases?Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.Towards the elimination and eradication of hepatitis B.An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9 CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Transgenic Clustered Regularly Interspaced Short Palindromic Repeat/Cas9-Mediated Viral Gene Targeting for Antiviral Therapy of Bombyx mori Nucleopolyhedrovirus.Gene therapeutic approaches to inhibit hepatitis B virus replication.CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.

P2860

Q26769662-3A428711-53A6-4B06-8963-14C1EA26BC99 Q26769907-6419FD30-9B9E-44BF-AC4A-BC72D1BE40B6 Q26772317-A348E484-2C53-4188-A10C-A9A6A772F134 Q26779150-698F97D6-3CEC-422D-BDEC-C2C10778F304 Q26799228-C2E11F0E-8EBF-4A81-B814-D02F8D191035 Q26861350-E27656BF-1CDB-4096-8457-E377794DF576 Q27011249-C9177612-200D-453A-ABC0-BAFD3B9874A1 Q27025675-AFC0C4FA-40E0-4590-8A04-9FD9FD8157ED Q28066970-C0A40FF9-9C70-48E4-9071-29F15647D775 Q28073697-08D88DC8-AAC1-422E-BAF4-982F72C5FED4 Q28078148-B317B6A7-3007-401B-89A1-AF36BF5B5D8A Q28081274-E5E5C776-099D-40F8-BE39-E49E08E6A4E3 Q28087380-9BADFA52-4515-4CFE-8420-D394A5A5A5EC Q28087526-4E0580D5-074F-447B-8AF9-F8B04BDB75F6 Q33559657-391505EF-D04F-4A55-8E8F-7A8521E00622 Q33765935-5B9136E5-E996-46B2-8D8F-150133985879 Q34047460-8B5F0F19-EBDF-4F22-BFF8-87F72EA9082A Q34478938-B80E8864-E61B-4007-87FA-120BF148F808 Q34507250-997D2C00-597C-4AE6-92C7-058A2DB440D4 Q34529971-B7328F2B-5522-49C8-ADA4-F13EE5BE68A8 Q34539796-717E149D-BAA1-4054-B672-54472695A439 Q35654689-E1DA5D1A-AE79-4324-A687-18C3EDC6ECF4 Q35770584-5F7BFF26-BC7F-4DC6-9325-9F3EB90246A8 Q35992385-391A1099-6FB1-443E-A9C3-ECF46CA63548 Q36196813-5027711A-7CED-433D-AA00-221FAD0BBDF0 Q36216276-ACC91DA4-3459-4203-BB73-B398DF8D5988 Q36386251-D1A73103-81FF-476D-AE6C-2BAC19B55AD6 Q36494284-18FE368B-FA6D-4B2C-B1B6-117BC24A598F Q36650962-A145F768-1CD5-44B1-93E2-C25C18D5C11A Q36730743-8310372E-C366-492A-B392-DA896168D13D Q36898145-268FECD7-2718-42D5-ABF4-51DEA00B0D68 Q36951290-5ABE66B8-0958-4487-B88E-E34C5B0FE4A4 Q37098214-8D1180C0-EF4A-4729-8F84-88E4FB524DAB Q37201993-9924E1EC-421F-4A02-83B6-5420D7535C0F Q37411994-29EEAB72-3C5E-42F5-90DF-A77F2487F6D9 Q37559174-545C241D-E378-4B65-B3FE-52BB7BA43D4E Q37714431-0D987464-F9BF-4B5A-AC70-AD4E6592D279 Q37732408-B72CCF77-5B1A-4482-B999-E1D94A5CD580 Q38366585-DB16A1A8-D9E7-4EEA-B182-58230FA9EA53 Q38516454-4CE6F47F-D6FA-4AD6-8542-9140CD8A7ED0

P2860

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

http://www.wikidata.org/entity/Q34459390

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@ast

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@en

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@nl

type

label

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@ast

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@en

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@nl

prefLabel

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@ast

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@en

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@nl

P1433

Q34459390-E755D2DA-D9A9-4472-AA78-E46B22CF5475

P1476

Q34459390-8B13FEDC-DCE7-4B84-BC98-4CC487C31253

P2093

Q34459390-1CCDEE3A-A847-4506-9948-2B81E920C6D4

Q34459390-4A52897C-849B-4D7A-9E12-800E1B636963

Q34459390-7DDCCDA3-6F6B-4434-99F1-8CDDB5406F44

Q34459390-88A1BD9B-EC60-4F51-8960-449823FED5E4

Q34459390-89464819-85E8-4B6F-990A-D0778ECFB863

Q34459390-89907DCE-B379-47D0-BAAE-FCFF83CBA235

Q34459390-987F19C1-DC9D-4B43-ACE8-C091659D4BA2

Q34459390-B25E7EBF-A3FA-4565-998E-921905448DC3

Q34459390-B3CF59BC-6198-4A45-914C-D2EB1DBC6C76

Q34459390-C5E32574-E7E3-4736-9D0B-92F947FCE2DD

P2860

Q34459390-000ED49F-FCC9-4F0A-B54D-16039B261CA0

Q34459390-051D14F4-E680-4731-B838-546526E4A2C3

Q34459390-180B1889-CAE2-4DD0-9C9A-34BCCA9CEDB4

Q34459390-18876317-4316-430E-8596-918EF4601678

Q34459390-23E33797-7434-4119-A402-C5F53287B747

Q34459390-25A61369-5F19-4364-B984-71EC8736B09B

Q34459390-2B544332-7C16-4F1A-8D8D-D22C6EC2B575

Q34459390-2E337D57-C030-49AA-93E8-A0BE66DA8FCA

Q34459390-314DD784-8349-422A-9096-4D088B3BE8FA

Q34459390-3FF8721E-4817-419B-8E3C-0E43D90FA4B8

P304

Q34459390-A373F805-05D6-4A20-ADE8-050D5C8D7859

P31

Q34459390-7DA7778B-3897-4724-B5CA-184B8E39058B

P356

Q34459390-40FD5E00-077D-490A-916B-EE2561881B63

P478

Q34459390-D35E95A0-85C5-4E7E-BF9C-C1D747F2986D

P50

Q34459390-DBE669D8-B103-46C7-B33B-891EA48835D9

Q34459390-EB265788-72D7-4D07-9ABF-FA176F11D89B

P577

Q34459390-BED57FF6-AD40-4F32-9EBD-FD7A26A71334

P5875

Q34459390-54D98A5D-2E14-49FC-8A8D-3BC3972A118A

P698

Q34459390-974E4597-7746-4363-B9C9-F47BEA0B949C

P921

Q34459390-6400FA38-3339-4592-B31F-87296C9ACD5B

P932

Q34459390-46FA953A-58B7-44A7-BB9D-433967B4E262

P356

P1433

Molecular therapy. Nucleic acids

P1476

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

@en

P2093

Chih-Chiang Wang

http://www.w3.org/2001/XMLSchema#string

Ding-Shinn Chen

http://www.w3.org/2001/XMLSchema#string

Fang-Yi Wu

http://www.w3.org/2001/XMLSchema#string

Hung-Chih Yang

http://www.w3.org/2001/XMLSchema#string

Hurng-Yi Wang

http://www.w3.org/2001/XMLSchema#string

Ku-Chun Sung

http://www.w3.org/2001/XMLSchema#string

Pei-Jer Chen

http://www.w3.org/2001/XMLSchema#string

Su-Ru Lin

http://www.w3.org/2001/XMLSchema#string

Ta-Yu Yang

http://www.w3.org/2001/XMLSchema#string

Yi-Ting Kuo

http://www.w3.org/2001/XMLSchema#string

P2860

RNA-guided human genome engineering via Cas9

Heritable genome editing in C. elegans via a CRISPR-Cas9 system.

Multiplex genome engineering using CRISPR/Cas systems

Efficient genome editing in zebrafish using a CRISPR-Cas system

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach

RNA-programmed genome editing in human cells

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Selective extraction of polyoma DNA from infected mouse cell cultures

P304

e186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2014.38

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264902803

http://www.w3.org/2001/XMLSchema#string

P698

25137139

http://www.w3.org/2001/XMLSchema#string

P921

P932

4221598

http://www.w3.org/2001/XMLSchema#string